NCT01447914 2019-08-28Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple MyelomaNational Cancer Institute (NCI)Phase 2 Completed16 enrolled 11 charts
NCT00211211 2017-12-08FREE Study - Fracture Reduction EvaluationMedtronic Spinal and BiologicsPhase 4 Completed300 enrolled